Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer – A first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study
- 30 September 2008
- journal article
- Published by Elsevier BV in Radiotherapy and Oncology
- Vol. 88 (3), 359-367
- https://doi.org/10.1016/j.radonc.2008.07.019
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Exceptionally high incidence of symptomatic grade 2–5 radiation pneumonitis after stereotactic radiation therapy for lung tumorsRadiation Oncology, 2007
- The North American Experience with Stereotactic Body Radiation Therapy in Non-small Cell Lung CancerJournal of Thoracic Oncology, 2007
- Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional StudyJournal of Thoracic Oncology, 2007
- Radiographic Response and Clinical Toxicity Following SBRT for Stage I Lung CancerJournal of Thoracic Oncology, 2007
- SBRT of lung tumours: Monte Carlo simulation with PENELOPE of dose distributions including respiratory motion and comparison with different treatment planning systemsPhysics in Medicine & Biology, 2007
- Optimizing Dose and Fractionation for Stereotactic Body Radiation TherapyPublished by S. Karger AG ,2007
- Aggravation of dyspnea in stage I non-small cell lung cancer patients following stereotactic body radiotherapy: Is there a dose-volume dependency?Acta Oncologica, 2006
- Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countriesActa Oncologica, 2006
- Dose distributions in SBRT of lung tumors: Comparison between two different treatment planning algorithms and Monte-Carlo simulation including breathing motionsActa Oncologica, 2006
- Dummy run for a phase II study of stereotactic body radiotherapy of T1-T2 N0M0 medical inoperable non-small cell lung cancerActa Oncologica, 2006